RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST
RVL Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Net Income | -68.27 | -51.69 | -64.92 | -79.59 | -270.9 | -109.68 |
Depreciation & Amortization | 0.38 | 0.38 | 8.18 | 21.03 | 51.05 | 71.68 |
Other Amortization | 1.13 | 3.06 | 3.07 | 1.77 | 7.31 | 12.42 |
Loss (Gain) From Sale of Assets | -0.95 | -0.88 | -4.46 | 0.29 | 0.17 | 0.09 |
Asset Writedown & Restructuring Costs | 27.21 | 13.31 | 7.88 | 72.18 | 283.75 | 104.22 |
Stock-Based Compensation | 2.38 | 4.07 | 7.59 | 4.93 | 4.93 | 1.97 |
Provision & Write-off of Bad Debts | - | - | - | 0.01 | -0.16 | -1.77 |
Other Operating Activities | -4.31 | -10.45 | -18.48 | -1.16 | -26.79 | -15.51 |
Change in Accounts Receivable | -0.1 | -0.9 | 7.11 | 17.5 | 12.67 | -17.04 |
Change in Inventory | -0.83 | 0.05 | 2.6 | 3.37 | 3.08 | -7.44 |
Change in Accounts Payable | -2.91 | -1.37 | -0.13 | -1.72 | -16.38 | -11.33 |
Change in Other Net Operating Assets | 1.84 | 6.6 | -17.03 | -21 | -15.16 | 9.95 |
Operating Cash Flow | -44.41 | -37.81 | -54.73 | 17.59 | 33.57 | 37.56 |
Operating Cash Flow Growth | - | - | - | -47.60% | -10.63% | -35.06% |
Capital Expenditures | -3.08 | -0.75 | -1.78 | -2.92 | -3.96 | -4.14 |
Sale of Property, Plant & Equipment | 0.95 | 0.88 | 0.09 | 0.05 | 0.02 | 0.01 |
Sale (Purchase) of Intangibles | - | - | 7.3 | - | - | - |
Other Investing Activities | - | - | 110.85 | -0.21 | -0.07 | - |
Investing Cash Flow | -2.13 | 0.13 | 116.45 | -3.08 | -4.02 | -4.13 |
Long-Term Debt Issued | - | 20.81 | 55.11 | - | 1.31 | 2.75 |
Long-Term Debt Repaid | - | -2.71 | -222.31 | -50.13 | -3.22 | -57.22 |
Net Debt Issued (Repaid) | 14.58 | 18.1 | -167.19 | -50.13 | -1.9 | -54.48 |
Issuance of Common Stock | 23.8 | 23.83 | 32.65 | 62.66 | - | 58.08 |
Repurchase of Common Stock | -0.1 | -0.14 | -0.78 | -8.85 | -2.79 | - |
Common Dividends Paid | - | - | - | - | - | -0 |
Financing Cash Flow | 38.28 | 41.78 | -135.33 | 3.68 | -4.69 | 3.6 |
Foreign Exchange Rate Adjustments | - | - | - | - | 0.18 | -0.94 |
Net Cash Flow | -8.25 | 4.1 | -73.61 | 18.19 | 25.03 | 36.09 |
Free Cash Flow | -47.49 | -38.56 | -56.51 | 14.67 | 29.6 | 33.41 |
Free Cash Flow Growth | - | - | - | -50.45% | -11.40% | -13.08% |
Free Cash Flow Margin | -128.62% | -77.56% | -322.92% | 52.84% | 12.33% | 12.67% |
Free Cash Flow Per Share | -0.49 | -0.43 | -0.84 | 0.24 | 0.56 | 0.74 |
Cash Interest Paid | 8.66 | 4.89 | 8.52 | 14.75 | 15.18 | 19.62 |
Cash Income Tax Paid | 0.12 | 0.18 | 2.36 | 2.04 | 1.29 | 2.64 |
Levered Free Cash Flow | -25.56 | -12.68 | -22.16 | -17.87 | 36.25 | 45.14 |
Unlevered Free Cash Flow | -25.94 | -13.8 | -23.33 | -17.08 | 46.3 | 55.61 |
Change in Working Capital | -1.99 | 4.39 | -7.46 | -1.86 | -15.78 | -25.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.